Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France
Alexandre J. Vivanti

, Jérémie Mattern, Christelle Vauloup-Fellous, Jacques Jani, Luc Rigonnot, Larissa El Hachem, Agnès Le Gouez, Céline Desconclois, Imane Ben M’Barek, Jeanne Sibiude, Alexandra Benachi, Olivier Picone, and Anne-Gaël Cordier
Author affiliations: Antoine Béclère Hospital, Paris Saclay University, Clamart, France (A.J. Vivanti, J. Mattern, A. Le Gouez, C. Desconclois, A. Benachi); Paul Brousse Hospital, Paris Saclay University, Villejuif, France (C. Vauloup-Fellous); University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium (J. Jani); Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, France (L. Rigonnot, L. El Hachem); Bicêtre Hospital, Paris Saclay University, Le Kremlin-Bicêtre, France (I. Ben M’Barek, A.-G. Cordier); Louis Mourier Hospital, Paris University, Colombes, France (J. Sibiude, O. Picone)
Main Article
Table 1
Baseline characteristics at diagnosis for pregnant women infected with sever acute respiratory syndrome 2, France*
Maternal and obstetric characteristics
|
Value
|
Total patients
|
100
|
Median age, y (IQR) |
33.7 (29–36.7) |
Median gravidity (IQR) |
3 (1.8–4) |
Median parity (IQR) |
1 (0–3) |
Median BMI, kg/m2 (IQR)
|
27.0 (23.5–30.6)
|
Preexisting conditions |
|
Diabetes mellitus |
7 (7) |
Chronic high blood pressure |
6 (6) |
Tobacco use |
2 (2) |
Asthma
|
9 (9)
|
Median gestational age at diagnosis, wk (IQR) |
31.3 (25.6–35.6) |
14–24 |
18 (18) |
25–32 |
41 (41) |
33–37 |
20 (20) |
>37 |
20 (20) |
Early postpartum
|
1 (1)
|
Signs and symptoms |
|
Fever |
62 (62) |
Cough |
80 (80) |
Dyspnea |
30 (30) |
Myalgia |
26 (26) |
Anosmia |
16 (16) |
Sore throat |
9 (9) |
Diarrhea or vomiting |
10 (10) |
Rash |
0 |
Other signs |
13 (13) |
Main Article
Page created: July 02, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.